| Literature DB >> 35901184 |
Gasim Omer Elkhalifa Abd-Elfarag1, Lukudu Emmanuel2, Arthur W D Edridge1,3, Stella van Beers4, Mohamed B Sebit5, Michaël B van Hensbroek1, Ente J J Rood4.
Abstract
BACKGROUND: Nodding syndrome (NS) is a progressive neurological disease that has been described in several sub-Saharan African counties, but South Sudan is considered the most affected. However, knowledge about the exact burden and the epidemiological risk factors of NS in South Sudan is lacking.Entities:
Mesh:
Year: 2022 PMID: 35901184 PMCID: PMC9362928 DOI: 10.1371/journal.pntd.0010630
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Nodding syndrome case definition.
Prevalence of nodding syndrome by Boma in Mundri East and West Counties, South Sudan.
| Name of boma | Number of participants surveyed (all age groups) | Number of participants surveyed (≤ 18 years) | Number of NS cases identified (all age groups) | Number of new NS cases (≤ 18 years) | Prevalence of NS (%, all age groups) | Prevalence of NS (%, ≤ 18 years) |
|---|---|---|---|---|---|---|
|
| 1307 | 778 | 32 | 14 | 2.4 | 1.8 |
|
| 606 | 469 | 15 | 1 | 2.5 | 0.2 |
|
| 2077 | 1182 | 72 | 4 | 3.5 | 0.3 |
|
| 517 | 256 | 71 | 8 | 13.7 | 3.1 |
|
| 458 | 260 | 16 | 2 | 3.5 | 0.8 |
|
| 805 | 468 | 18 | 3 | 2.2 | 0.6 |
|
| 2161 | 1294 | 27 | 3 | 1.2 | 0.2 |
|
| 1069 | 627 | 17 | 4 | 1.6 | 0.6 |
|
| 284 | 159 | 16 | 3 | 5.6 | 1.9 |
|
| 110 | 53 | 3 | 2 | 2.7 | 3.8 |
|
| 11384 | 6555 | 249 | 28 | 2.2 | 0.4 |
|
| 481 | 286 | 19 | 13 | 4.0 | 4.5 |
|
| 1152 | 696 | 52 | 29 | 4.5 | 4.2 |
| Total |
|
|
|
|
|
|
Univariate and multivariate analysis of risk factors for nodding syndrome, South Sudan.
| Covariates | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
| lagNS (spatial effect) | 6.9 (4.2–11.5) | 7.5 | 0.000*** | 5.3 (3.2–9.1) | 6.2 | 0.000*** |
|
| ||||||
| Cows | 1.2 (0.8–1.7) | 0.9 | 0.367 | |||
| Goats | 1.1 (0.8–1.4) | 0.7 | 0.485 | |||
| Sheep | 1.3 (0.7–2.4) | 0.8 | 0.396 | |||
| Poultry | 1.4 (1.1–1.8) | 2.8 | 0.006** | 1.45 (1.13–1.88) | 2.9 | 0.004** |
|
| ||||||
| Television | 0.6 (0.3–1.2) | -1.4 | 0.161 | |||
| Mobile phone | 0.7 (0.5–0.9) | -3.3 | 0.001*** | 0.72 (0.57–0.92) | -2.6 | 0.009** |
| Motorcycle | 0.9 (0.6–1.2) | -0.9 | 0.380 | |||
| Bicycle | 1.0 (0.7–1.3) | -0.2 | 0.826 | |||
| Car | 0.5 (0.1–1.3) | -1.3 | 0.189 | |||
|
| ||||||
| Borehole | 0.6 (0.4–1.0) | -2.1 | 0.038* | |||
| Well | 1.2 (0.3–4.5) | 0.3 | 0.776 | |||
| Spring | 4.8 (0–1.97) | 0.0 | 0.986 | |||
| Rain | 0.00 | 0.0 | 0.986 | |||
| River | 1.9 (1.1–3.2) | 2.5 | 0.014** | |||
| Pond | 0.3 (0.0–1.1) | -1.6 | 0.112 | |||
| Tanker | 1.3(0–4.78) | 0.0 | 0.983 | |||
|
| ||||||
| Borehole | 0.6 (0.4–1.0) | -1.9 | 0.056* | |||
| Well | 0.9 (0.2–3.2) | -0.1 | 0.930 | |||
| Spring | 1.3 (0–4.78) | 0.0 | 0.983 | |||
| Rain | 2.9 (0.3–24.1) | 1.0 | 0.295 | |||
| River | 1.8 (1.1–3.1) | 2.3 | 0.024* | |||
| Pond | 0.4 (0.1–1.2) | -1.5 | 0.131 | |||
|
| ||||||
| Borehole | 0.6 (0.4–1.0) | -1.9 | 0.061 | |||
| Well | 0.9 (0.2–3.2) | -0.1 | 0.930 | |||
| Spring | 4.8 (0–1.97) | 0.0 | 0.986 | |||
| Rain | 1.9 (0.2–11.6) | 0.7 | 0.484 | |||
| River | 1.8 (1.1–3.0) | 2.3 | 0.024* | |||
| Pond | 0.6 (0.2–1.3) | -1.2 | 0.213 | |||
|
| ||||||
| Borehole | 0.7 (0.4–1.1) | -1.7 | 0.090 | |||
| Well | 1.3 (0.3–4.0) | 0.4 | 0.697 | |||
| Spring | 4.8 (0–8.27) | 0.0 | 0.984 | |||
| Rain | 2.9 (0.5–15.8) | 1.3 | 0.199 | |||
| River | 1.8 (1.1–3.0) | 2.2 | 0.028* | |||
| Pond | 0.3 (0.1–0.9) | -2.0 | 0.048* | |||
| Tanker | 1.0 (1.0–1.2) | 1.2 | 0.220 | |||
|
| ||||||
| Moved from study area | 0.9 (0.6–1.2) | -0.9 | 0.383 | |||
| Lived in IDP camps | 0.8 (0.4–1.3) | -0.7 | 0.502 | |||
|
| ||||||
| Ate smaller meal size | 1.0 (0.5–1.9) | 0.1 | 0.923 | |||
| Ate fewer meal frequency | 1.0 (0.5–1.9) | 0.1 | 0.923 | |||
| Ate no meal | 1.3 (0.9–1.8) | 1.3 | 0.193 | |||
| Ate poor quality meal | 1.1 (0.5–1.9) | 0.2 | 0.870 | |||
|
| ||||||
| River distance | 0.9 (0.9–1.0) | -2.5 | 0.014** | 0.93 (0.88–0.97) | -0.3 | 0.002*** |
|
| ||||||
| Ivermectin intake | 1.46 (0.97–2.21) | -8.5 | 0.021* | |||
OR = Odds Ratio, CDTI = Community Directed Treatment with Ivermectin
Significance level: P-value ≤ 0.001 ***, P-value ≤ 0.01 **, P-value ≤ 0.05 *